COST ANALYSIS OF EMERGENCY VISITS DUE TO DRUG RELATED PROBLEMS
Objective: To identify patients coming to Emergency Medicine Department (EMD) with drug related problems, classify the DRPs and calculate the direct cost spent for treating them.
Methods: This was a prospective observational study conducted in emergency medicine department. The patients coming to EMD with DRPs were classified according to Cipolle’s classification and the direct medical and non-medical costs were calculated.
Results: A total of around 107 patients identified with DRPs of which 99 patients were included in the study. In this study, 51% of the cases were due to ADR and 35% due to non-adherence and rest of the cases were due to overdose (10%), drug interaction (3%) and sub therapeutic dose (1%). Major portion for treatment was spent for direct medical cost in which cost for laboratory investigations have contributed the most, INR 10,93,992 (42%) followed by Health care professional cost INR 55,6814 (21%), Pharmacy cost INR 4,00,524.6 (15%), Admission cost INR 3,80,400 (15%). The direct non-medical cost includes cost for diet and travel which was found to be INR 1,68,443 and INR 71,947 respectively.
Conclusion: The drug related problems adds a significant economic burden on the patients which can be reduced by imparting knowledge about the proper use of medicines and by improving collaborative efforts of the patients, physicians, pharmacists and caregivers.
2. Adusumilli PK, Adepu R. Drug-related problems: an overview of various classification systems. Asian J Pharm Clin Res 2014;7:7-10.
3. Sundus Basharat. Management of drug-related hospital admissions. Int J Sci Res Publications 2016;6:63-7.
4. Shankar PR, Partha P, Shenoy N. Self-medication and non-doctor prescription practices in pokhara valley, Western Nepal: a questionnaire-based study. BMC Fam Pract 2002;3:17.
5. Selvaraj K, Kumar SG, Ramalingam A. Prevalence of self-medication practices and its associated factors in Urban Puducherry, India. Perspect Clin Res 2014;5:32–6.
6. Johnson JA, Bootman JL. Drug-relatedmorbidityandmortality: acost-of-illnessmodel. Arch Int Med 1995;155:1949–56.
7. Gabriel Rodrigues Martins de Freitas, Mariana Younes Tramontina, Giacomo Balbinotto, Dyfrig Arwyn Hughes, Isabela Heineck. Economic impact of emergency visits due to drug-related morbidity on a Brazilian Hospital. Value Health Regional Issue 2017;14C:1-8.
8. Smita Pattanaik, Punit Dhamija, Samir Malhotra, Navneet Sharma, Promila Pandhi. Evaluation of cost of treatment of drug-related events in a public care tertiary sector. Br J Clin Pharmacol 2009;67:363-9.
9. Baena MI, Faus MJ, Fajardo PC, Luque FM, Sierra F, Martinez Olmos J, et al. Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol 2006;62:387-93.
10. Peter J Zed, Riyad B Abu-Laban, Robert M Balen, Peter S Loewen, Corinne M Hohl MD, Jeffrey R Brubacher, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. Canadian Med Assoc Licensors 2008;178:1563-9.
11. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother 1999;33:1252-7.
12. Sarfaraz Mohammed, Sanjay Poudel, Fernance Laloo, Arjun Madhur, Rinson Robert, Binu Mathew. Assessment of drug-related problems in a tertiary care teaching hospital, india. Asian J Pharm Clin Res 2017;10:310-3.
13. Peter J Zed, Karen JL Black, Eleanor A Fitzpatrick, Stacy Ackroyd Stolarz, Nancy G Murphy, Janet A Curran, et al. Medication-related emergency department visits in pediatrics: a prospective observational study. Pediatrics 2018;135:435-43.
This work is licensed under a Creative Commons Attribution 4.0 International License.